News Updates

Day: July 29, 2025

Mavenir Completes Comprehensive Recapitalization

Transaction eliminates more than $1.3 billion of existing debt and secures $300 million of new senior financing, meaningfully strengthening Mavenir’s balance sheet. Mavenir well-positioned for sustained growth and long-term success. Siris remains controlling shareholder with support from key existing Mavenir lenders. RICHARDSON, Texas, July 29, 2025 (GLOBE NEWSWIRE) — Mavenir, the

Continue Reading...

Nyxoah’s DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine

Nyxoah’s DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine Mont-Saint-Guibert, Belgium – July 28, 2025, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA), today announced that

Continue Reading...